康瑞龙,邓勇志

• 1:山西省心血管病医院(研究所)山西医科大学附属心血管病医院山西省心血管病临床医学研究中心心血管外科

摘要(Abstract)：

卵圆孔未闭(PFO)作为一种常见的先天性心脏结构变异，广泛存在于普通人群中。近年来已有多项针对PFO相关疾病的大规模随机对照试验得出结论，随着循证医学证据的积累，对PFO封堵术适应证的讨论也愈发激烈。本文通过综述PFO封堵术在循证医学方面最新的里程碑数据，重点探讨PFO封堵术适应证的把控和相关器械的更新，深入分析术后新发心房颤动的临床意义，并结合国内外最新指南为临床介入治疗提供参考。

关键词(KeyWords)： 卵圆孔未闭;卵圆孔未闭相关性卒中;卵圆孔未闭相关非卒中性疾病;卵圆孔未闭封堵术

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 康瑞龙,邓勇志

DOI: 10.13201/j.issn.1001-1439.2026.10.014

参考文献(References)：

• [1]Hagen PT,Scholz DG,Edwards WD.Incidence and size of patent foramen ovale during the first 10decades of life:an autopsy study of 965normal hearts[J].Mayo Clin Proc,1984,59(1):17-20．
• [2]Meissner I,Whisnant JP,Khandheria BK,et al.Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography:the SPARC study.Stroke Prevention:Assessment of Risk in a Community[J].Mayo Clin Proc,1999,74(9):862-869．
• [3]Hoffman JIE,Kaplan S.The incidence of congenital heart disease[J].J Am Coll Cardiol,2002,39(12):1890-1900．
• [4]Cohnheim J.Thrombose und embolie[M].Vorlesungen??ber Allgemeine Pathologie.Berlin:Hirschwald,1877:134．
• [5]Nellessen U,Daniel WG,Matheis G,et al.Impending paradoxical embolism from atrial thrombus:correct diagnosis by transesophageal echocardiography and prevention by surgery[J].J Am Coll Cardiol,1985,5(4):1002-1004．
• [6]Bridges ND,Hellenbrand W,Latson L,et al.Transcatheter closure of patent foramen ovale after presumed paradoxical embolism[J].Circulation,1992,86(6):1902-1908．
• [7]Brogno D,Lancaster G,Rosenbaum M.Embolism interruptus[J].N Engl J Med,1994,330(24):1761-1762．
• [8]Mas JL,Derumeaux G,Guillon B,et al.Patent foramen ovale closure or anticoagulationvs.antiplatelets after stroke[J].N Engl J Med,2017,377(11):1011-1021．
• [9]S??ndergaard L,Kasner SE,Rhodes JF,et al.Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke[J].N Engl J Med,2017,377(11):1033-1042．
• [10]Saver JL,Carroll JD,Thaler DE,et al.Long-term outcomes of patent foramen ovale closure or medical therapy after stroke[J].N Engl J Med,2017,377(11):1022-1032．
• [11]Lee PH,Song JK,Kim JS,et al.Cryptogenic stroke and high-risk patent foramen ovale:the DEFENSE-PFO trial[J].J Am Coll Cardiol,2018,71(20):2335-2342．
• [12]MesséSR,Gronseth GS,Kent DM,et al.Practice advisory update summary:Patent foramen ovale and secondary stroke prevention:Report of the Guideline Subcommittee of the American Academy of Neurology[J].Neurology,2020,94(20):876-885．
• [13]Kavinsky CJ,Szerlip M,Goldsweig AM,et al.SCAIguidelines for the management of patent foramen ovale[J].J Soc Cardiovasc Angiogr Interv,2022,1(4):100039．
• [14]Nachoski D,Schroeder J,Almalla M,et al.Dual-center experiences with interventional closure of patent foramen ovale:a medium-term follow-up study comparing two patient groups aged under and over 60years[J].Clin Cardiol,2021,44(3):386-391．
• [15]中华医学会心血管病学分会，中华心血管病杂志编辑委员会．卵圆孔未闭规范化诊疗中国专家共识[J]．中华心血管病杂志，2024,52(4):369-383．
• [16]Kent DM,Wang AY.Patent foramen ovale and stroke:a review[J].JAMA,2025,334(16):1463．
• [17]中国人体健康科技促进会结构性心脏病专委会，中国医师协会神经内科分会，张玉顺，等．卵圆孔未闭相关非卒中性疾病防治中国专家共识[J]．心脏杂志，2024,36(2):125-134．
• [18]Guo YC,Shi YJ,Zhu D,et al.Clopidogrel can be an effective complementary prophylactic for drug-refractory migraine with patent foramen ovale[J].J Investig Med,2020,68(7):1250-1255．
• [19]Del Sette M,Angeli S,Leandri M,et al.Migraine with aura and right-to-left shunt on transcranial Doppler:a case-control study[J].Cerebrovasc Dis,1998,8(6):327-330．
• [20]Wilmshurst PT,Nightingale S,Walsh KP,et al.Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons[J].Lancet,2000,356(9242):1648-1651．
• [21]Dowson A,Mullen MJ,Peatfield R,et al.Migraine Intervention With STARFlex Technology(MIST)trial:a prospective,multicenter,double-blind,sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache[J].Circulation,2008,117(11):1397-1404．
• [22]Mattle HP,Evers S,Hildick-Smith D,et al.Percutaneous closure of patent foramen ovale in migraine with aura,a randomized controlled trial[J].Eur Heart J,2016,37(26):2029-2036．
• [23]Tobis JM,Charles A,Silberstein SD,et al.Percutaneous closure of patent foramen ovale in patients with migraine:the PREMIUM trial[J].J Am Coll Cardiol,2017,70(22):2766-2774．
• [24]中华医学会神经病学分会，中华医学会神经病学分会头痛协作组．中国偏头痛诊断与治疗指南（中华医学会神经病学分会第一版）[J]．中华神经科杂志，2023,56(6):591-613．
• [25]Zhang Y,Wang HJ,Liu L.Patent foramen ovale closure for treating migraine:a meta-analysis[J].J Interv Cardiol,2022,2022:6456272．
• [26]Ben-Assa E,Rengifo-Moreno P,Al-Bawardy R,et al.Effect of residual interatrial shunt on migraine burden after transcatheter closure of patent foramen ovale[J].JACC Cardiovasc Interv,2020,13(3):293-302．
• [27]Mojadidi MK,Kumar P,Mahmoud AN,et al.Pooled analysis of PFO occluder device trials in patients with PFO and migraine[J].J Am Coll Cardiol,2021,77(6):667-676．
• [28]Moon R,Camporesi E,Kisslo J.Patent foramen ovale and decompression sickness in divers[J].Lancet,1989,333(8637):513-514．
• [29]Pristipino C,GermonpréP,Toni D,et al.European position paper on the management of patients with patent foramen ovale.Part II-Decompression sickness,migraine,arterial deoxygenation syndromes and select high-risk clinical conditions[J].Eur Heart J,2021,42(16):1545-1553．
• [30]Honěk J，Srámek M，Sefc L,et al.High-grade patent foramen ovale is a risk factor of unprovoked decompression sickness in recreational divers[J].J Cardiol,2019,74(6):519-523．
• [31]GermonpréP,Lafère P,Portier W,et al.Increased risk of decompression sickness when diving with a rightto-left shunt:results of a prospective single-blinded observational study(the“carotid Doppler”study)[J].Front Physiol,2021,12:763408．
• [32]Vanden Eede M,Van Berendoncks A,de Wolfe D,et al.Percutaneous closure of patent foramen ovale for the secondary prevention of decompression illness in sports divers:mind the gap[J].Undersea Hyperb Med,2019,46(5):625-632．
• [33]Honěk J，Srámek M,Honěk T,et al.Patent foramen ovale closure is effective in divers:long-term results from the DIVE-PFO registry[J].J Am Coll Cardiol,2020,76(9):1149-1150．
• [34]Honěk J，Srámek M,Honěk T,et al.Screening and risk stratification strategy reduced decompression sickness occurrence in divers with patent foramen ovale[J].JACC Cardiovasc Imaging,2022,15(2):181-189．
• [35]Abdelfattah OM,Sayed A,Elgendy IY,et al.Patent foramen ovale closure and decompression sickness among divers[J].Cardiovasc Revasc Med,2022,40:160-162．
• [36]Rasines-Rodríguez A,Otero González A,Salgado Fernández J,et al.Platypnea-orthodeoxia syndrome(POS):a retrospective study of percutaneous closure of the foramen ovale in a single center[J].Cathet Cardio Intervent,2025,106(1):698-701．
• [37]DI Muro FM,Compagnone M,Santoro G,et al.Percutaneous closure of patent foramen ovale in patients with platypnea-orthodeoxia syndrome:an Italian multicenter experience[J].Minerva Cardiol Angiol.2025Jul 2,doi:10.23736/S2724-5683.25.06841-3．
• [38]Wong R,McClure T,Saleem D,et al.Paradoxical embolism leading to myocardial infarction:revisiting the significance of patent foramen ovale[J].JACC Case Rep,2025,30(31):105330．
• [39]Pristipino C,Carroll J,Mas JL,et al.Treatment of patent foramen ovale[J].EuroIntervention,2025,21(10):505-524．
• [40]Caso V,Turc G,Abdul-Rahim AH,et al.European Stroke Organisation(ESO)Guidelines on the diagnosis and management of patent foramen ovale(PFO)after stroke[J].Eur Stroke J,2024,9(4):800-834．
• [41]林大卫，周达新．卵圆孔未闭研究现状与进展[J]．中华心脏与心律电子杂志，2024,12(2):65-71．
• [42]Yamashita E,Murata T,Goto E,et al.Inferior vena Cava Compression as a novel maneuver to detect patent foramen ovale:a transesophageal echocardiographic study[J].J Am Soc Echocardiogr,2017,30(3):292-299．
• [43]Yang XX,Wang H,Wei YJ,et al.Diagnosis of patent foramen ovale:the combination of contrast transcranial Doppler,contrast transthoracic echocardiography,and contrast transesophageal echocardiography[J].Biomed Res Int,2020,2020:8701759．
• [44]Xiong L,Zeng YT,Gan T,et al.Assessing patent foramen ovale on coronary computed tomographic angiography:a comparison with transesophageal echocardiography[J].Jpn J Radiol,2022,40(7):689-695．
• [45]Kavvouras C,Vavuranakis M,Vaina S,et al.Intracardiac echocardiography for percutaneous patent foramen ovale and atrial septal defect occlusion[J].Herz,2019,44(5):445-449．
• [46]Yeh RW,DeFaria Yeh D.Patent foramen ovale closure-harnessing clinical trial evidence to inform individualized treatment decisions[J].JAMA,2021,326(22):2265-2267．
• [47]Gaspardone A,de Marco F,Sgueglia GA,et al.Novel percutaneous suture-mediated patent foramen ovale closure technique:early results of the NobleStitch ELItalian Registry[J].EuroIntervention,2018,14(3):e272-e279．
• [48]Zannoni J,Popolo Rubbio A,Tusa MB,et al.Mechanisms of ineffective patent foramen ovale closure using the percutaneous suture-mediated NobleStitch system[J].EuroIntervention,2022,18(1):68-70．
• [49]Baldetti L,Ferri LA,Ancona M,et al.Interatrial septal tear after patent foramen ovale closure with the NobleStitch device[J].JACC Cardiovasc Interv,2019,12(16):e139-e140．
• [50]Du YJ,Xie H,Shao H,et al.A prospective,single-center,phase I clinical trial to evaluate the value of transesophageal echocardiography in the closure of patent foramen ovale with a novel biodegradable occluder[J].Front Cardiovasc Med,2022,9:849459．
• [51]Song L,Shi PX,Zheng XZ,et al.Echocardiographic characteristics of transcatheter closure of patent foramen ovale with mallow biodegradable occluder:a single-center,phase III clinical study[J].Front Cardiovasc Med,2022,9:945275．
• [52]He L,Xie H,Gao YS,et al.Biodegradable Pansy??occluder for patent foramen ovale closure:a multicenter,single-arm,prospective study[J].Front Cardiovasc Med,2025,12:1464712．
• [53]Ouyang WB,Jiang H,Yan XX,et al.Bioresorbable vs metallic occluders for transcatheter atrial septal defect closure:a randomized clinical trial[J].JAMA,2025,334(19):1740．
• [54]李爱敏，何建新，张迎，等．MemoSorb??生物可降解封堵器卵圆孔未闭封堵术后近期疗效观察1例[J]．中国介入心脏病学杂志，2024,32(3):168-171．
• [55]Zhang FW,Dong J,Wei PJ,et al.Transcatheter closure of patent foramen ovale with a novel biodegradable device:aprospective,multicenter,randomized controlled clinical trial[J].Circulation,2026,153(2):71-81．
• [56]Li RL,Huang JJ,Ming J,et al.Comparative efficacy and safety of nitinol vs.novel fully biodegradable occluders for transcatheter patent foramen ovale closure in migraine treatment:a retrospective cohort study[J].Front Med,2025,12:1613687．
• [57]Li BY,Zeng HW,Xie H,et al.Safety and efficacy of a novel biodegradable occluder-Pansy??occluder compared with traditional nondegradable occluder in the closure of patent foramen ovale[J].Front Cardiovasc Med,2026,13:1704287．
• [58]中国人体健康科技促进会结构性心脏病专业委员会，张玉顺，秦永文，等．生物可降解卵圆孔未闭封堵器临床应用路径中国专家共识[J]．心脏杂志，2025,37(6):621-629．
• [59]国家结构性心脏病质量管理与控制中心专业委员会，国家心血管病专家委员会结构性心脏病专业委员会，潘湘斌．中国生物可降解卵圆孔未闭封堵器临床操作专家建议[J]．中国循环杂志，2025,40(8):752-761．
• [60]Baron SJ.Atrial fibrillation after percutaneous PFOclosure:not so rare after all[J].JACC Cardiovasc Interv,2022,15(22):2323-2325．
• [61]Apostolos A,Tsiachris D,Drakopoulou M,et al.Atrial fibrillation after patent foramen ovale closure:incidence,pathophysiology,and management[J].J Am Heart Assoc,2024,13(9):e034249．
• [62]Ujka K,Pizzuto A,Giordano M,et al.Prevalence,classification,and treatment of residual shunt after patent foramen ovale closure[J].EuroIntervention,2025,21(16):933-941．
• [63]李炜杰，蒋威，温健恒，等．卵圆孔解剖特征对经皮卵圆孔未闭介入封堵术的影响[J]．临床心血管病杂志，2024,40(5):421-425.